Signs, Symptoms, and Diagnosis of Osteonecrosis of the Jaw - Exposure of mandibular or maxillary bone through non-healing lesions in the gingiva - Presence of pain, inflammation, secondary infection, or drainage - Lesions most commonly develop after invasive dental procedures or spontaneously - Lesions are more common on the mandible than the maxilla - Symptoms may include pain, neuropathy, erythema, suppuration, bad breath, and difficulty in keeping the mouth clean - ONJ is classified based on severity, number of lesions, and lesion size - Grades range from asymptomatic (grade 1) to severe (grade 4) - Lesion size is measured as the largest diameter - Multiple lesions can be present in ONJ - Diagnosis involves evaluating symptoms and radiographic evidence - Routine imaging techniques like radiographs are not effective in detecting cancellous bone and marrow damage - No specific radiographic findings are exclusive to bone infarction/osteonecrosis - Through-transmission alveolar ultrasound combined with panoramic dental radiography can help assess changes in jawbone density - Up-to-date understanding of the disease process, detailed clinical findings, and various imaging modalities aid in early diagnosis

Causes and Risk Factors of Osteonecrosis of the Jaw - Toxic agents, such as infections and chronic diseases, can affect blood flow and contribute to bone infarct and ischemia - Heavy metals like lead and cadmium have been implicated in osteoporosis and hypofibrinolysis - Bisphosphonates, commonly used for osteoporosis treatment, have been associated with osteonecrosis of the jaw (ONJ) - Bisphosphonate-associated ONJ was first reported in cancer patients receiving chemotherapy - Dental extractions are often a precipitating factor for ONJ in bisphosphonate users - The mandible is more commonly affected than the maxilla in bisphosphonate-associated ONJ (2:1 ratio) - Dental surgical procedures often precede ONJ cases - Oversuppression of bone turnover is the primary mechanism for the development of bisphosphonate-associated ONJ - Patients taking glucocorticoids like dexamethasone are at an increased risk of ONJ - Matrix metalloproteinase 2 may be a candidate gene associated with bisphosphonate-associated ONJ

Management and Treatment of Osteonecrosis of the Jaw - Antibiotics are ineffective in treating ONJ due to the lack of blood supply to the bone - Surgical management, including the removal of necrotic bone, improves circulation and reduces microorganisms - ONJ makes eating and drinking difficult, and surgical intervention can alleviate these challenges - Bisphosphonate drugs have a prolonged embedding in bone tissues, increasing the risk of ONJ even after stopping the medication - Bone health involves more than just bone mineral density, and bisphosphonates do not address all factors contributing to bone health - Nutrient absorption and elimination of metabolic wastes are important in treatment - Conservative debridement of necrotic bone, pain control, infection management, and use of antimicrobial oral rinses are preferred over aggressive surgical measures - Complete cessation of bisphosphonate therapy for at least 6 months may show some improvement in non-surgical cases - Repeat surgeries may be required for ONJ patients, especially in multiple sites within the jaws - Research is ongoing to explore non-surgical therapeutic modalities that can improve prognosis and reduce morbidity

Effects and Pathophysiology of Osteonecrosis of the Jaw - ONJ can have necrotic bone or bone marrow that is nutrient-starved - Blood flow impairment occurs following a bone infarct - Histopathological alterations include fatty degeneration, necrosis, and marrow fibrosis - ONJ can affect the hips, knees, and jaws - Infections in the oral cavity can worsen the blood flow problem in ONJ - Cancellous bone is more susceptible to damage by bone infarcts - Osteocytes have a lifespan of 15 years in cancellous bone and 25 years in cortical bone - Altered osteoblastic function plays a role in ON of the femoral head - Premature cell death can occur within 12-48 hours in bone cells - Necrotic bone does not undergo resorption - Histopathological changes in ONJ are similar to other forms of osteonecrosis - Trabeculae in femoral head may have intact osteocytes but reduced collagen synthesis - ONJ can cause severe facial pain and may be associated with neuralgia-inducing cavitational osteonecrosis (NICO)

History and Future Directions of Osteonecrosis of the Jaw - ONJ has been documented since around 1850, with cases linked to environmental pollutants and medications containing mercury, arsenic, or bismuth - The disease primarily targeted the mandible and caused localised or generalised deep ache or pain - Diagnosis was often delayed due to the lack of visible clinical signs and limitations of imaging techniques - Bone infarcts mediated by local and systemic factors are now recognised as the cause of ONJ - Improved understanding and early diagnosis can be achieved through a combination of medical history, clinical findings, and imaging modalities - Research is ongoing to develop effective treatments for bisphosphonate-associated bone lesions - Minimizing or correcting known causes is crucial while further research is conducted on chronic ischemic bone diseases like ONJ - Some osteonecrosis patients have responded to anticoagulation therapies alone - The earlier the diagnosis, the better the prognosis for ONJ - Greater emphasis on understanding and addressing the disease process is needed to reduce the morbidity of ONJ